Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guidant (GDT) -- Ignore unavailable to you. Want to Upgrade?

To: Glenn Petersen who wrote (224)	6/13/2003 9:07:27 PM
From: Ausdauer	Read Replies (1) \| Respond to of 235

Glenn, GDT is up since its nadir several months ago, but I think management really leaves a lot to be desired. First, the way the coated stent issue was handled was poor and now the AAA stent issue which really will rattle investor confidence in management and stain the reputation of this great company. The coated stent issue just gets worse and worse... Message 17949433 Now GDT may owe $425 to JNJ for patent infringement. (For the record I have no position in this company.) Aus